Cargando…
No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients
BACKGROUND: Mast cells promote the progression of experimental tumors and might be a valuable therapeutic target. However, the relevant clinical evidence is still controversial. This study analyzed the relationship between the distribution of mast cells and the survival of patients with colon cancer...
Autores principales: | Xia, Qing, Wu, Xiao-Jun, Zhou, Qiang, Jing-Zeng, Hou, Jing-Hui, Pan, Zhi-Zhong, Zhang, Xiao-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128057/ https://www.ncbi.nlm.nih.gov/pubmed/21651824 http://dx.doi.org/10.1186/1479-5876-9-88 |
Ejemplares similares
-
Higher percentage of CD133(+ )cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
por: Li, Chun-Yan, et al.
Publicado: (2009) -
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer
por: Peng, Rui-Qing, et al.
Publicado: (2010) -
Survival Contradiction in Stage II, IIIA, And IIIB Colon Cancer: A Surveillance, Epidemiology, and End Result-Based Analysis
por: Li, Yijun, et al.
Publicado: (2022) -
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC
por: Agrawal, Vishesh, et al.
Publicado: (2017) -
Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer
por: WEN, MEILING, et al.
Publicado: (2014)